Cargando…

MR-proADM as prognostic factor of outcome in COVID-19 patients

Mid Regional pro-ADM (MR-proADM) is a promising novel biomarker in the evaluation of deteriorating patients and an emergent prognosis factor in patients with sepsis, septic shock and organ failure. It can be induced by bacteria, fungi or viruses. We hypothesized that the assessment of MR-proADM, wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sozio, Emanuela, Tascini, Carlo, Fabris, Martina, D’Aurizio, Federica, De Carlo, Chiara, Graziano, Elena, Bassi, Flavio, Sbrana, Francesco, Ripoli, Andrea, Pagotto, Alberto, Giacinta, Alessandro, Gerussi, Valentina, Visentini, Daniela, De Stefanis, Paola, Merelli, Maria, Saeed, Kordo, Curcio, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933259/ https://www.ncbi.nlm.nih.gov/pubmed/33664308 http://dx.doi.org/10.1038/s41598-021-84478-1

Ejemplares similares

Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study
por: Peghin, Maddalena, et al.
Publicado: (2022)

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience
por: Tascini, Carlo, et al.
Publicado: (2020)

CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial
por: Sozio, Emanuela, et al.
Publicado: (2021)

The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
por: Sozio, Emanuela, et al.
Publicado: (2023)

Author Correction: The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
por: Sozio, Emanuela, et al.
Publicado: (2023)

Pericardial Cytokine “Storm” in a COVID-19 Patient: the Confirmation of a Hypothesis
por: Deana, Cristian, et al.
Publicado: (2021)

Recognition in Emergency Department of Septic Patients at Higher Risk of Death: Beware of Patients without Fever
por: Sozio, Emanuela, et al.
Publicado: (2021)

MR-proADM as Prognostic Factor of Outcome in COVID-19 Patients
por: Cameli, Paolo, et al.
Publicado: (2023)

The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery
por: Peghin, Maddalena, et al.
Publicado: (2021)

Dataset of the associations of aldosterone to renin ratio with MR-proANP and MR-proADM
por: Then, Cornelia, et al.
Publicado: (2016)

MR-proADM and MR-proANP levels in patients with acute pulmonary embolism
por: Öner, Önsel, et al.
Publicado: (2020)

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply
por: De Monte, Amato, et al.
Publicado: (2021)

Possible tattoo-transmitted monkeypox viral infection
por: Tascini, Carlo, et al.
Publicado: (2022)

Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis
por: Bais, Bruno, et al.
Publicado: (2022)

Application of MR-ProADM to predict prevention of hospitalisation, derived from a multi-centre study
por: Cullinan, Milo, et al.
Publicado: (2019)

Role of MR-proADM in the risk stratification of COVID-19 patients assessed at the triage of the Emergency Department
por: Minieri, Marilena, et al.
Publicado: (2021)

Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients
por: Peghin, Maddalena, et al.
Publicado: (2021)

Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
por: Önal, Uğur, et al.
Publicado: (2018)

The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections
por: Baumann, Philipp, et al.
Publicado: (2022)

1542. MR-proADM Biomarker Predicts COVID-19 Clinical Outcomes: a US-based Cohort Study
por: Mansour, Michael
Publicado: (2022)

Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19
por: Peghin, Maddalena, et al.
Publicado: (2021)

Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery
por: Beltrami, Antonio Paolo, et al.
Publicado: (2022)

D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis
por: Meini, Simone, et al.
Publicado: (2021)

Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection
por: Da Porto, Andrea, et al.
Publicado: (2022)

Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients
por: García de Guadiana-Romualdo, Luis, et al.
Publicado: (2021)

Comparison between procalcitonin and C-reactive protein to predict blood culture results in ICU patients
por: Bassetti, Matteo, et al.
Publicado: (2018)

Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients
por: Peghin, Maddalena, et al.
Publicado: (2022)

Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency Department
por: Minieri, Marilena, et al.
Publicado: (2022)

Low risk of nosocomial severe acute respiratory syndrome-coronavirus-2 infection in patients with liver disease admitted to a hepatology unit at an academic hospital: A single-center experience
por: Toniutto, Pierluigi, et al.
Publicado: (2022)

Ischemic strokes in COVID-19: risk factors, obesity paradox, and distinction between trigger and causal association
por: Janes, Francesco, et al.
Publicado: (2023)

Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients
por: Fabris, Martina, et al.
Publicado: (2022)

Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study
por: Vigué, Bernard, et al.
Publicado: (2016)

Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis
por: Liu, Dan, et al.
Publicado: (2016)

Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure control
por: Iwao, Motoshi, et al.
Publicado: (2021)

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study
por: Gar, Christina, et al.
Publicado: (2022)

The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia
por: Graziano, Elena, et al.
Publicado: (2022)

Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score
por: Travaglino, Francesco, et al.
Publicado: (2012)

Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care
por: Quartuccio, Luca, et al.
Publicado: (2020)

The TRIAGE-ProADM Score for an Early Risk Stratification of Medical Patients in the Emergency Department - Development Based on a Multi-National, Prospective, Observational Study
por: Kutz, Alexander, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_javm1gvooki48uuhvcgs0sg9gk